Stonebridge Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-605
Closed -$60K 966
2019
Q3
$60K Sell
605
-22,462
-97% -$2.13M 0.01% 298
2019
Q2
$2.13M Sell
23,067
-2,705
-10% -$257K 0.38% 74
2019
Q1
$2.43M Sell
25,772
-938
-4% -$82K 0.45% 68
2018
Q4
$1.71M Sell
26,710
-3,822
-13% -$282K 0.4% 72
2018
Q3
$2.73M Sell
30,532
-165
-0.5% -$14.6K 0.55% 61
2018
Q2
$2.44M Buy
30,697
+17,455
+132% +$1.45M 0.53% 61
2018
Q1
$1.18M Buy
13,242
+1,700
+15% +$163K 0.27% 89
2017
Q4
$1.21M Sell
11,542
-195
-2% -$22K 0.28% 87
2017
Q3
$1.71M Sell
11,737
-335
-3% -$45.6K 0.42% 73
2017
Q2
$1.57M Buy
12,072
+260
+2% +$31.9K 0.41% 76
2017
Q1
$1.47M Buy
11,812
+40
+0.3% +$4.79K 0.4% 80
2016
Q4
$1.36M Sell
11,772
-945
-7% -$105K 0.4% 81
2016
Q3
$1.33M Buy
12,717
+490
+4% +$53K 0.42% 82
2016
Q2
$1.21M Buy
12,227
+945
+8% +$97.8K 0.41% 82
2016
Q1
$1.13M Buy
11,282
+345
+3% +$35.5K 0.4% 82
2015
Q4
$1.31M Buy
10,937
+1,497
+16% +$173K 0.48% 70
2015
Q3
$1.02M Buy
9,440
+935
+11% +$116K 0.41% 75
2015
Q2
$984K Buy
8,505
+575
+7% +$65.7K 0.38% 80
2015
Q1
$914K Buy
7,930
+2,755
+53% +$329K 0.35% 81
2014
Q4
$579K Buy
5,175
+605
+13% +$63.8K 0.24% 97
2014
Q3
$433K Buy
4,570
+1,200
+36% +$108K 0.19% 106
2014
Q2
$289K Sell
3,370
-90
-3% -$6.84K 0.13% 118
2014
Q1
$242K Buy
+3,460
New +$274K 0.12% 123

Other funds holding CELG

Stonebridge Capital Advisors's CELG Position: Q4 2019 in Review

Stonebridge Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 605 shares — an estimated $60K sold.

Stonebridge Capital Advisors first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $2.73M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stonebridge Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 605 Celgene Corp shares in Q4 2019, an estimated $60K.
  • Stonebridge Capital Advisors first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Stonebridge Capital Advisors's Celgene Corp position peaked at $2.73M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.